BrainTale Secures 1M€ Seed Round
11/09/20, 1:39 PM
Location
parisRound Type
seed
BrainTale, a French innovative company dedicated to enabling adapted care for brain injured patients in clinical routine with its portfolio of quantification and prediction digital medical devices in neurology and intensive care, announced the completion of its first financing round securing more than 1M€ of funding.
Company Info
Location
paris, ile de france, france
Additional Info
About BrainTale
BrainTale is an innovative company opening a new era in medicine providing physicians with clinically validated prognosis solutions for the management of brain injured patient through sensitive and reliable measurements of brain microstructure alterations. BrainTale’s products are based on medical needs understanding, fulfilling healthcare professionals and patients’ expectations and is built upon more than 15 years of clinical development.
ISO :13485 :2016 certified, BrainTale has launched its first product brainQuant earlier in 2020.
For more information, please visit www.braintale.fr